Andrew Kennedy, MD
Physician-in-Chief, Radiation Oncology, Sarah Cannon; Director, Radiation Oncology Research
Dr. Kennedy joined Sarah Cannon in 2012 as the physician-in-chief of radiation oncology and the director of radiation oncology research at Sarah Cannon Research Institute. He is responsible for strategic development of radiation oncology services for the HCA Enterprise and development of radiation oncology research program within Sarah Cannon Research Institute.
Kennedy is a graduate of the Loma Linda School of Medicine in California, and completed his residency at The University of North Carolina at Chapel Hill. He is an internationally renowned radiation oncologist specializing in gastrointestinal, breast and lung cancers, brachytherapy and stereotactic approaches. Nationally, he served as a member of the Board of Chancellors for the American College of Radiation Oncology and is a Fellow of the College. He has been selected yearly since 2009 as one of America’s Best Doctors (top 5 percent of U.S.), and was inducted into Alpha Omega Alpha (AOA) Honor Society as a faculty member in 1999.